Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease

被引：2
|
作者：
Nizari, Shereen [1 ,2 ]
Hawkes, Cheryl A. [3 ]
Hattori, Yorito [4 ]
Mishra, Anusha [5 ,6 ]
机构：
[1] UCL, Ctr Adv Biomed Imaging, Div Med, London, England
[2] UCL, Ctr Cardiovasc & Metab Neurosci, Dept Neurosci Physiol & Pharmacol, London, England
[3] Univ Lancaster, Dept Biomed & Life Sci, Lancaster, England
[4] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Japan
[5] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR USA
[6] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Dept Neurol, Portland, OR USA
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2022年 / 14卷
关键词：
neurovascular unit (NVU); cerebrovascular disease; biomarker; cerebral blood flow (CBF); therapeutic target;
D O I：
10.3389/fnagi.2022.908716
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease
    Unzeta, Mercedes
    Hernandez-Guillamon, Mar
    Sun, Ping
    Sole, Montse
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [42] Endothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseases
    Jinqiang Zhu
    Wanshan Song
    Lin Li
    Xiang Fan
    Molecular Brain, 9
  • [43] Endothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseases
    Zhu, Jinqiang
    Song, Wanshan
    Li, Lin
    Fan, Xiang
    MOLECULAR BRAIN, 2016, 9
  • [44] CD49d is a disease biomarker and a potential therapeutic target in Duchenne muscular dystrophy
    Mariz, F. Pinto
    Rodrigues Carvalho, L.
    Araujo, A. P. Q.
    de Mello, W.
    Ribeiro, M. G.
    Cunha, M. C. S.
    Riederer, I.
    Negroni, E.
    Mouly, V.
    Voit, T.
    Desguerre, I.
    Butler-Browne, G.
    Savino, W.
    Silva-Barbosa, S. D.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 655 - 655
  • [45] Plasma IgA as a biomarker and IL-21 as a potential therapeutic target in Inflammatory Bowel Disease
    Tsai, T.
    Hsu, J. L.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I981 - I982
  • [46] YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease
    Muszynski, Pawel
    Groblewska, Magdalena
    Kulczynska-Przybik, Agnieszka
    Kulakowska, Alina
    Mroczko, Barbara
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (06) : 906 - 917
  • [47] A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease
    Gessi, Stefania
    Poloni, Tino Emanuele
    Negro, Giulia
    Varani, Katia
    Pasquini, Silvia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Merighi, Stefania
    CELLS, 2021, 10 (09)
  • [48] Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
    Janeiro, Manuel H.
    Ramirez, Maria J.
    Milagro, Fermin I.
    Alfredo Martinez, J.
    Solas, Maite
    NUTRIENTS, 2018, 10 (10)
  • [49] Contactin 1: A potential therapeutic target and biomarker in gastric cancer
    De-Hu Chen
    Ji-Wei Yu
    Bo-Jian Jiang
    World Journal of Gastroenterology, 2015, (33) : 9707 - 9716
  • [50] Oxytocin receptor epigenetics: from biomarker to potential therapeutic target
    Burris, Heather H.
    White, Lauren K.
    Waller, Rebecca
    Chaiyachati, Barbara H.
    PEDIATRIC RESEARCH, 2024,
12345